Current Assets
Inventories
Regeneron Pharmaceuticals Inventories decreased by 3.0% to $3.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.8%, from $3.19B to $3.10B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 10.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
An increase might suggest overproduction or weakening demand, while a decrease could indicate strong sales or potential supply chain shortages.
Detailed definition
The carrying value of raw materials, work-in-process, and finished goods awaiting sale to consumers or enterprise client...
Peer comparison
Consumer electronics firms strive for high inventory turnover to mitigate the risk of rapid technological depreciation.
Metric ID:
inventoriesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.98B | $2.05B | $1.95B | $1.99B | $2.22B | $2.41B | $2.40B | $2.42B | $2.51B | $2.56B | $2.58B | $2.71B | $2.87B | $3.02B | $3.09B | $3.19B | $3.21B | $3.25B | $3.20B | $3.10B |
| QoQ Change | — | +3.5% | -5.0% | +2.1% | +11.4% | +8.7% | -0.4% | +0.9% | +3.4% | +2.2% | +0.7% | +5.2% | +5.8% | +5.0% | +2.3% | +3.4% | +0.4% | +1.5% | -1.6% | -3.0% |
| YoY Change | — | — | — | — | +11.8% | +17.5% | +23.1% | +21.8% | +13.0% | +6.2% | +7.4% | +12.0% | +14.6% | +17.8% | +19.6% | +17.6% | +11.6% | +7.8% | +3.7% | -2.8% |
Range$1.95B – $3.25B
CAGR+9.9%
Avg YoY Growth+12.7%
Median YoY Growth+12.5%
Current Streak2 quarters decline
Inventories at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's inventories?
- Regeneron Pharmaceuticals (REGN) reported inventories of $3.10B in Q1 2026.
- How has Regeneron Pharmaceuticals's inventories changed year-over-year?
- Regeneron Pharmaceuticals's inventories decreased by 2.8% year-over-year, from $3.19B to $3.10B.
- What is the long-term trend for Regeneron Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's inventories has grown at a 10.8% compound annual growth rate (CAGR), from $1.92B to $3.20B.
- What does inventories mean?
- The value of products currently being manufactured or held in stock ready to be sold.